Professor Steven le Gouill from the Medical University of Nantes in France believes that there are still many uncertainties related to the optimal management of mantle cell lymphoma. In this podcast, he describes his treatment approach in frontline therapy and relapsed refractory disease, while pointing out aspects of ongoing debate. Part 2 of the podcast ...
Episode 2: Mantle Cell Lymphoma: personalised approaches are still the best strategy
14 Aug 2019
Sponsored by Janssen-Cilag Pty Ltd